Preclinical Imaging Market Size, Forecast, Growth, Trends 2024-2033

The preclinical imaging market size has grown strongly in recent years. It will grow from $3.2 billion in 2023 to $3.44 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to government initiatives, growing prevalence of diseases, expanding applications, increasing awareness, emerging markets expansion.

The preclinical imaging market size is expected to see strong growth in the next few years. It will grow to $4.42 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to personalized medicine adoption, advancements in molecular imaging, drug development outsourcing, regulatory support, rising chronic diseases. Major trends in the forecast period include green imaging technologies, technological advancements, rise in r&d activities, collaborations and partnerships, real-time imaging.

Market Overview -

Preclinical imaging refers to the techniques used to visualize and study biological processes in animal models before being applied to human clinical trials. These imaging techniques allow researchers to track disease progression, evaluate the efficacy and safety of potential therapeutics, and gain insights into the biological mechanisms underlying diseases.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Rising Chronic Disease Burden Fuels Preclinical Imaging Market Growth
The increase in chronic diseases is expected to propel the growth of the preclinical imaging market going forward. Chronic diseases refer to long-term health conditions that persist for an extended period, typically lasting for three months or more. These diseases often require ongoing medical management and can significantly impact a person's quality of life. For identifying chronic diseases, preclinical imaging tools are used for visualizing the bone structure and lung function. It is also used to study chronic diseases to visualize the progression of the disease and improve disease understanding. For instance, in September 2022, according to the World Health Organization (WHO) 2022 Highlights, a Switzerland-based intergovernmental health organization, there were 41 million deaths, which is 74% of all deaths caused by Noncommunicable diseases (NCDs) or chronic diseases every year globally. Among them are 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, increasing chronic disease is driving the growth of the preclinical imaging market.

Competitive Landscape -

Major companies operating in the preclinical imaging market report are Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, EKF Diagnostics Holdings plc., Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

Revolutionizing Preclinical Imaging Through Cutting-Edge Technology And Flexibility

Product innovations are a key trend gaining popularity in the preclinical imaging market. Major companies operating in the preclinical imaging market are developing innovative products to sustain their position in the market. For instance, in May 2022, Fujifilm VisualSonics Inc., a Canada-based biomedical company that manufactures imaging systems, launched Vevo F2 for preclinical imaging. This innovative product is the first preclinical ultra-high- to low-frequency (71 MHz-1 MHz) ultrasonic and photoacoustic imaging system. The Vevo F2 features HD image processing technology and a completely new signal pathway, enabling better image clarity and better frame rates. The system is also customizable to fit the specific precision demands of imaging. Additionally, it includes features such as HD image processing technology, a completely new signal pathway, customizable system architecture, a wide range of anatomical targets, and high-resolution imaging. It is suitable for a variety of research applications.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Key Segments -

The preclinical imaging market covered in this report is segmented -

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User

Key highlights covered in the report -

1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.